Deciphering cancer complexities in genetically engineered mice
Abstract:
Because the pRb pathway is disrupted in most solid human cancers, we have generated genetically engineered mouse cancer models by inactivating pRb function in several cell types, including astrocytes and mammary, prostate, ovarian, and brain choroid plexus epithelia. In every case, proliferation and apoptosis are acutely induced, predisposing to malignancy. Cell type dictates the pathways involved in tumor progression. In the astrocytoma model, we developed strategies to induce events in the adult brain, either throughout the tissue or focally. Both K-Ras activation and Pten inactivation play significant roles in progression. In the prostate model, adenocarcinoma progression depends on Pten inactivation. However, nonautonomous induction of p53 in the mesenchyme leads to evolution of both compartments, with p53 loss occurring in the mesenchyme. Thus, studies in these models continue to identify key tumorigenesis mechanisms. Furthermore, we are hopeful that the models will provide useful preclinical systems for diagnostic and therapeutic development.
Insights
Inactivating the pRb pathway in mice triggers rapid cell proliferation and apoptosis, leading to cancer. Tumor progression pathways vary by cell type, offering insights into cancer development and preclinical research.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The retinoblastoma (pRb) pathway is frequently disrupted in human solid cancers.
- Understanding pRb's role is crucial for cancer research and therapeutic development.
Purpose of the Study:
- To generate and characterize genetically engineered mouse models (GEMMs) with inactivated pRb function in various epithelial cell types.
- To investigate cell-type-specific mechanisms driving tumor progression.
- To identify key tumorigenesis pathways for potential diagnostic and therapeutic targets.
Main Methods:
- Inactivation of pRb function in mouse models across multiple cell types (astrocytes, mammary, prostate, ovarian, choroid plexus epithelia).
- Induction of specific oncogenic events (e.g., K-Ras activation, Pten inactivation) to study tumor progression.
- Analysis of proliferation, apoptosis, and molecular pathways involved in tumorigenesis.
Main Results:
- Inactivation of pRb consistently induced acute proliferation and apoptosis, predisposing to malignancy across all tested cell types.
- Tumorigenesis pathways were cell-type-dependent; K-Ras activation and Pten inactivation were significant in astrocytoma progression.
- Prostate adenocarcinoma progression was linked to Pten inactivation, with nonautonomous p53 induction in the mesenchyme playing a role.
Conclusions:
- GEMMs with pRb inactivation are valuable tools for studying cancer mechanisms.
- Cell-type-specific pathways are critical in cancer progression, highlighting the need for tailored therapeutic strategies.
- These models offer promising preclinical systems for advancing cancer diagnostics and therapeutics.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...